Research and Development

The FDA has struck out against a wave of companies offering cancer treatments online which fraudulently claim to be able …

Scientists have identified a marker which they believe can inform whether a tumour will become more aggressive and pose a …

In a move that is sure to pile even more pressure onto Mylan after the company’s recent woes, Sanofi has …

The latest edition of Pharmafocus is available to read now! In this issue we delve into pharma’s reaction to the …

Rasna Therapeutics, the UK-based biotech that specialises in developing treatments for leukaemia, has announced the appointment of a new CEO. …

Heads of research from 19 of the biggest players in the industry have called for a decision to be made …

A recent study, published in the British Journal of General Practice, has found that 23% of those suffering from cancer …

7 April marked this year’s World Health Day, and for 2017 the WHO selected depression as the annual focus. Prevalent …

Researchers from the Universities of Exeter and Alberta have identified a protein in the brain which they believe could be …

Bristol-Myers Squibb’s UK General Manager Ben Hickey has slammed NICE over its assessment criteria and process in recommending access to …

Another week has whizzed round again as we race into Spring, and a breadth of stories have piqued the interests …

Alexander Hitchcock and Eleonora Harwich, researchers at UK think tank Reform, discuss the increasing importance of big data in the …

AbbVie have released that two Phase 3 trials of its experimental cancer drug, veliparib, missed both of their primary endpoints. …

A team of scientists at Medical Research Council’s (MRC) Toxicology Unit in Leicester, UK have identified methods to prevent neurodegeneration …

Research from GlobalData has suggested that an investigational drug from ImmunoGen could prove effective in treating platinum-resistant ovarian cancer, an …